Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39038

DNAAF9 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

DNAAF9 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from HEK293T embryonic kidney cells, disrupting the DNAAF9 gene required for cytoplasmic pre-assembly of dynein arm complexes in motile cilia. DNAAF9 interacts with DNAAF1, DNAAF2, and CCDC103 to facilitate outer and inner dynein arm formation, and its loss impairs ciliary motility. This model enables studies of primary ciliary dyskinesia and ciliogenesis, and supports screening of therapeutics targeting motile ciliopathies. Suitable assays include immunofluorescence for ciliary markers, high-speed video microscopy, and western blotting for dynein proteins.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DNAAF9

    Gene Identifier

    NCBI Gene ID 25943

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAAF9 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-mediated gene-disrupted polyclonal population derived from the Homo sapiens HEK293T embryonic kidney epithelial cell line, targeting the DNAAF9 (dynein axonemal assembly factor 9, also known as CILD12) gene. DNAAF9 encodes a cytoplasmic factor essential for the pre-assembly of axonemal dynein arm complexes required for motile cilia function. The polyclonal product format provides a heterogeneous mixture of edited cells, enabling pooled loss-of-function studies without clonal isolation, and is well-suited for investigations where genetic diversity within the knockout population is informative.

HEK293T cells are a standard host for recombinant protein expression, stably harboring the SV40 large T-antigen to allow episomal plasmid replication and high-level protein production. Although they do not generate motile cilia, their human embryonic kidney epithelial origin and excellent transfectability make them a practical biochemical platform for analyzing ciliary protein expression, assembly, and interactions. Notably, under serum-free culture conditions, HEK293T cells can be induced to form primary cilia, permitting simplified studies of early ciliogenesis and the subcellular localization of dynein arm assembly factors including DNAAF9.

DNAAF9 functions in the cytoplasmic pre-assembly of dynein arm complexes, directly interacting with assembly factors such as DNAAF1, DNAAF2, DNAAF3, and coiled-coil domain-containing proteins CCDC103, CCDC39, and CCDC40, as well as outer dynein heavy chains DNAH5 and DNAH11. This network is transcriptionally regulated by FOXJ1 and RFX family master regulators of motile ciliogenesis, with additional modulation from Notch signaling and hypoxia-inducible factor HIF1A. DNAAF9-dependent assembly is essential for outer and inner dynein arm integrity, which governs ciliary beat frequency and mucociliary clearance; consequently, loss of DNAAF9 leads to immotile cilia and ciliopathic phenotypes such as primary ciliary dyskinesia.

Within the HEK293T cellular context, the DNAAF9 knockout model enables focused biochemical dissection of dynein arm assembly mechanisms, circumventing the complexity of multi-ciliated cell models. The host line??s high transfection efficiency and protein overexpression capacity facilitate rescue experiments to map critical functional domains of DNAAF9, as well as interaction studies using co-immunoprecipitation or proximity ligation assays. Induction of primary cilia under serum starvation further allows investigation of DNAAF9??s role in early ciliogenesis and the localization of its interaction partners, providing a reductionist yet informative system for studying assembly factor dynamics.

This polyclonal knockout cell population is intended for advanced research applications including the biochemical characterization of dynein arm assembly, high-content screening of small molecules that modulate DNAAF9 function or its interactome, and mechanistic modeling of primary ciliary dyskinesia and related conditions such as Kartagener syndrome. Compatible assays include western blotting for dynein proteins, RT-qPCR analysis of ciliogenesis-related gene expression, and immunofluorescence microscopy for DNAAF9 and its partners. Comparative phenotypic analyses between knockout and wild-type HEK293T cells under ciliogenic conditions can reveal functional deficits. For further information, protocol guidance, or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)